ATE130096T1 - Verfahren zur verstärkung des emissionssignals einer lumineszierenden verbindung. - Google Patents

Verfahren zur verstärkung des emissionssignals einer lumineszierenden verbindung.

Info

Publication number
ATE130096T1
ATE130096T1 AT91913539T AT91913539T ATE130096T1 AT E130096 T1 ATE130096 T1 AT E130096T1 AT 91913539 T AT91913539 T AT 91913539T AT 91913539 T AT91913539 T AT 91913539T AT E130096 T1 ATE130096 T1 AT E130096T1
Authority
AT
Austria
Prior art keywords
amplifying
emission signal
luminescent compound
luminescent
compound
Prior art date
Application number
AT91913539T
Other languages
English (en)
Inventor
Gerard Mathis
Christophe Dumont
Daniel Aspe
Muriel Foyentin
Etienne Jean-Pierre Jolu
Dominique Nuti
Original Assignee
Cis Bio Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cis Bio Int filed Critical Cis Bio Int
Application granted granted Critical
Publication of ATE130096T1 publication Critical patent/ATE130096T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Luminescent Compositions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT91913539T 1990-07-13 1991-07-12 Verfahren zur verstärkung des emissionssignals einer lumineszierenden verbindung. ATE130096T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9008981A FR2664699B1 (fr) 1990-07-13 1990-07-13 Procede d'amplification du signal d'emission d'un compose luminescent.

Publications (1)

Publication Number Publication Date
ATE130096T1 true ATE130096T1 (de) 1995-11-15

Family

ID=9398708

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91913539T ATE130096T1 (de) 1990-07-13 1991-07-12 Verfahren zur verstärkung des emissionssignals einer lumineszierenden verbindung.

Country Status (11)

Country Link
US (1) US5512493A (de)
EP (1) EP0539477B1 (de)
JP (1) JP3117459B2 (de)
AT (1) ATE130096T1 (de)
AU (1) AU8198091A (de)
DE (1) DE69114499T2 (de)
DK (1) DK0539477T3 (de)
ES (1) ES2082217T3 (de)
FR (1) FR2664699B1 (de)
GR (1) GR3018429T3 (de)
WO (1) WO1992001225A1 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399397B1 (en) 1992-09-14 2002-06-04 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US6159686A (en) 1992-09-14 2000-12-12 Sri International Up-converting reporters for biological and other assays
US5736410A (en) 1992-09-14 1998-04-07 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US6238931B1 (en) * 1993-09-24 2001-05-29 Biosite Diagnostics, Inc. Fluorescence energy transfer in particles
FR2735238B1 (fr) * 1995-06-09 1997-09-05 Cis Bio Int Utilisation d'un complexe phycobiliproteine-peptide de liaison en tant que traceur fluorescent
FI963989A (fi) * 1996-10-04 1998-04-05 Wallac Oy Homogeenisiä määritysmenetelmiä, jotka perustuvat luminesenssienergiasiirtoon
US20050227294A1 (en) * 1997-09-15 2005-10-13 Molecular Devices Corporation Molecular modification assays involving lipids
US7745142B2 (en) 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US7632651B2 (en) * 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
FR2769315B1 (fr) * 1997-10-03 2001-06-08 Cis Bio Int Conjugues fluorescents de nucleosides ou de nucleotides, leur procede de preparation et leur utilisation
AU2679899A (en) 1998-02-18 1999-09-06 Dade Behring Inc. Chemiluminescent compositions for use in detection of multiple analytes
EP1925320A3 (de) 1998-03-27 2008-09-03 Prolume, Ltd. Luciferasen, fluoreszierende Proteine, Nukleinsäuren zur Kodierung der Luciferasen und der fluoreszierenden Proteine sowie deren Verwendung zur Diagnose, zum Screening mit hohem Durchsatz und zur Behandlung neuartiger Probleme
FR2778744B1 (fr) 1998-05-14 2000-06-23 Cis Bio Int Dosage immunologique de la chromogranine a humaine (cga) anticorps, reactifs et trousses utilisables pour ce dosage
US5998146A (en) * 1998-07-17 1999-12-07 Wallac Oy Homogeneous luminescence assay method based on energy transfer
US6235479B1 (en) 1999-04-13 2001-05-22 Bio Merieux, Inc. Methods and devices for performing analysis of a nucleic acid sample
FR2809817B1 (fr) * 2000-06-02 2003-08-15 Cis Bio Int Procede de detection de presence d'un liquide dans un melange
DE10153829A1 (de) 2001-11-05 2003-05-28 Bayer Ag Assay basierend auf dotierten Nanoteilchen
EP1355158A1 (de) 2002-04-19 2003-10-22 B.R.A.H.M.S Aktiengesellschaft Verfahren zur Diagnose von Entzündungserkrankungen und Infektionen unter Bestimmung des Phosphoproteins LASP-1 als Inflammationsmarker
EP1355159A1 (de) * 2002-04-19 2003-10-22 B.R.A.H.M.S Aktiengesellschaft Verwendungen von Fragmenten der Carbamoylphosphat Synthetase 1 (CPS 1) für die Diagnose von Entzündungserkrankungen und Sepsis
WO2004042019A2 (en) * 2002-10-30 2004-05-21 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
US20040241748A1 (en) * 2003-02-10 2004-12-02 Dana Ault-Riche Self-assembling arrays and uses thereof
US20050095648A1 (en) * 2003-10-30 2005-05-05 Mario Geysen Method for designing linear epitopes and algorithm therefor and polypeptide epitopes
US20060018911A1 (en) * 2004-01-12 2006-01-26 Dana Ault-Riche Design of therapeutics and therapeutics
US20060024757A1 (en) * 2004-07-30 2006-02-02 Robert Hussa Detection of oncofetal fibronectin for selection of concepti
DE102004045705A1 (de) 2004-09-21 2006-04-06 B.R.A.H.M.S Ag Verwendungen der Carbamoylphosphat Synthetase 1(CPS) als humoraler Biomarker für die Diagnose von Tumorerkrankungen und chronisch entzündlichen Darmerkrankungen
CA2581639C (en) * 2004-09-30 2016-07-26 Molecular Devices Corporation Luminescent lanthanide complexes
DE102006021406B4 (de) 2006-05-08 2008-08-07 B.R.A.H.M.S Aktiengesellschaft In vitro Verfahren zur Früherkennung von arznei- und suchtmittelinduzierten Leberschäden und zur Erkennung der bereits erreichten Stufe der Leberschädigung
DE102007009751A1 (de) 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
DE102007022367A1 (de) 2007-05-07 2008-11-20 B.R.A.H.M.S Ag Verfahren zur Bestimmung von aminoterminalen pro-ANP bei übergewichtigen Patienten
US20130183696A1 (en) 2010-09-15 2013-07-18 Constance Neely Wilson Methods of use and kit for measurement of lipopolysaccharide with a time resolved fluorescence based assay
US9653691B2 (en) * 2012-12-12 2017-05-16 Universal Display Corporation Phosphorescence-sensitizing fluorescence material system
WO2016063304A1 (en) 2014-10-21 2016-04-28 Council Of Scientific & Industrial Research Luminescent lanthanide complexes and method of preparation thereof
US10138267B2 (en) 2015-04-06 2018-11-27 Hunan Skyworld Biotechnologies Co. Ltd. Bioconjugates of heterocyclic compounds
US20180348235A1 (en) 2015-11-27 2018-12-06 B.R.A.H.M.S Gmbh MR-proADM as marker for the extracellular volume status of a subject
AU2017210215B2 (en) 2016-01-21 2022-09-08 SeLux Diagnostics, Inc. Methods for rapid antimicrobial susceptibility testing
US9834808B2 (en) 2016-01-21 2017-12-05 SeLux Diagnostics, Inc. Methods for rapid antibiotic susceptibility testing
FR3051556A1 (fr) * 2016-05-18 2017-11-24 Biocytex Utilisation de marqueurs fluorescents pour la detection de cible biologique dans un echantillon
WO2018029213A1 (en) 2016-08-09 2018-02-15 B.R.A.H.M.S Gmbh Histones and/or proadm as markers indicating organ dysfunction
JP7104689B2 (ja) 2016-08-09 2022-07-21 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 有害事象を示すマーカーとしてのヒストンおよび／またはｐｒｏＡＤＭ
BR112019012979A2 (pt) 2016-12-23 2019-12-31 Selux Diagnostics Inc métodos para o teste de suscetibilidade antimicrobiana rápida melhorada
CA3052349A1 (en) 2017-02-02 2018-08-09 B.R.A.H.M.S Gmbh Proadm as marker indicating an adverse event
US20200225248A1 (en) 2017-05-31 2020-07-16 B.R.A.H.M.S Gmbh Mmp-8 as a marker for identifying infectious disease
CN111065922A (zh) 2017-09-13 2020-04-24 B.R.A.H.M.S有限公司 肾上腺髓质素原作为危重病患者的肾脏替代治疗的指标
CA3075440A1 (en) 2017-09-13 2019-03-21 B.R.A.H.M.S Gmbh Pro-adm as a therapy monitoring marker for critcally ill patients
ES2909399T3 (es) 2017-09-13 2022-05-06 Brahms Gmbh Proadrenomedulina como marcador de niveles anormales de plaquetas
DK3682241T3 (da) 2017-09-13 2022-05-16 Brahms Gmbh Pct og pro-adm som markører til monitorering af antibiotikabehandling
EP3502691A1 (de) 2017-12-20 2019-06-26 B.R.A.H.M.S GmbH Proadrenomedullin als indikator für nierenersatztherapie bei kritisch kranken patienten
JP7344208B2 (ja) 2017-12-20 2023-09-13 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング ｐｒｏ－ＡＤＭに基づく抗生物質療法の指導
JP7444776B2 (ja) 2017-12-20 2024-03-06 ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 併存症を有する患者におけるプロカルシトニンに基づく抗生物質療法のガイダンス
EP3578989A1 (de) 2018-06-06 2019-12-11 B.R.A.H.M.S GmbH Pro-adm zur prognose von traumabedingten komplikationen bei polytraumapatienten
EP3608673A1 (de) 2018-08-08 2020-02-12 B.R.A.H.M.S GmbH Pro-adm zur prognose des risikos einer erkrankung, die einen krankenhausaufenthalt bei patienten mit symptomen einer infektionskrankheit erfordert
WO2020156988A1 (en) 2019-01-28 2020-08-06 B.R.A.H.M.S Gmbh Method to predict treatment response in patients with nocturnal enuresis
CA3126202A1 (en) 2019-02-21 2020-08-27 B.R.A.H.M.S Gmbh Diagnosis or prognosis of postsurgical adverse events
CA3124744A1 (en) 2019-03-29 2020-10-08 B.R.A.H.M.S Gmbh Prescription of remote patient management based on biomarkers
EP3715851A1 (de) 2019-03-29 2020-09-30 B.R.A.H.M.S GmbH Verschreibung von fernpatientenmanagement auf der basis von biomarkern
CA3152541A1 (en) 2019-08-27 2021-03-04 SeLux Diagnostics, Inc. Systems and methods for performing antimicrobial susceptibility testing
BR112022017489A2 (pt) 2020-04-06 2022-10-18 Brahms Gmbh Pró adrenomedulina para prognóstico da progressão da doença na síndrome respiratória aguda grave (sars)
WO2021204984A1 (en) 2020-04-09 2021-10-14 B.R.A.H.M.S Gmbh Biomarkers for the diagnosis of respiratory tract infections
WO2023104975A1 (en) 2021-12-08 2023-06-15 B.R.A.H.M.S Gmbh Biomarkers for prognosis of early onset preeclampsia
WO2023110832A1 (en) 2021-12-13 2023-06-22 UNIVERSITé LAVAL Biomarkers for the prediction of preterm birth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4542104A (en) * 1983-04-06 1985-09-17 The Board Of Trustees Of The Leland Stanford Jr. Univ. Phycobiliprotein fluorescent conjugates
FR2570703B1 (fr) * 1984-09-26 1988-07-08 Commissariat Energie Atomique Complexes macropolycycliques de terres rares et application a titre de marqueurs fluorescents
JPS61128169A (ja) * 1984-11-27 1986-06-16 Mitsubishi Chem Ind Ltd 免疫分析法
US4822733A (en) * 1985-05-28 1989-04-18 Amoco Corporation Lifetime-resolved assay procedures
EP0272320B1 (de) * 1986-06-17 1994-03-23 Baxter Diagnostics Inc. Homogenes fluortestverfahren mit abstoss des fluorzenten hintergrundes.
FR2624862B1 (fr) * 1987-12-18 1990-06-08 Oris Ind Cryptates de terres rares, procedes d'obtention, intermediaires de synthese et application a titre de marqueurs fluorescents
GB8820887D0 (en) * 1988-09-06 1988-10-05 Atomic Energy Authority Uk Detecting selected species

Also Published As

Publication number Publication date
DE69114499D1 (de) 1995-12-14
WO1992001225A1 (fr) 1992-01-23
FR2664699B1 (fr) 1995-08-18
DK0539477T3 (da) 1995-12-11
EP0539477B1 (de) 1995-11-08
US5512493A (en) 1996-04-30
JPH06500852A (ja) 1994-01-27
EP0539477A1 (de) 1993-05-05
FR2664699A1 (fr) 1992-01-17
GR3018429T3 (en) 1996-03-31
ES2082217T3 (es) 1996-03-16
DE69114499T2 (de) 1996-03-28
JP3117459B2 (ja) 2000-12-11
AU8198091A (en) 1992-02-04

Similar Documents

Publication Publication Date Title
ATE130096T1 (de) Verfahren zur verstärkung des emissionssignals einer lumineszierenden verbindung.
DE3873842T2 (de) Verfahren zur gen-amplifikation.
DE69213112T2 (de) Verbesserte Methoden zur Nukleinsäure-Amplifizierung
ATE21173T1 (de) Methode zur fluoreszenz-spektroskopischen bestimmung von biologisch aktiven substanzen.
DE69223284D1 (de) Methoden zur Bestimmung von Krebsmetastasen mittels Nukleinsäuren-Amplifikation
DE3669271D1 (de) Verfahren zur entseuchung des bodens.
DE59204440D1 (de) Verfahren zur Erkennung von Verbrennungsaussetzern.
PT97580A (pt) Sondas de proteina-acido nucleico e imunoensaios que utilizam as mesmas
DE69105978T2 (de) Verfahren zur verminderung von störungen in einer fluoreszenzbestimmung.
RU92016387A (ru) Молекулярные зонды, способы амплификации
DE69009922T2 (de) Vorrichtung zur magnetischen Defekterkennung für Stahlbänder.
DE60143888D1 (de) Methode um die sensitivität einer luminesenz assay zu erhöhen
DE3871226D1 (de) Verfahren zur abschaetzung von scherwellenreflexionsmesswerten aus erfassten kompressionswellenreflexionsmesswerten.
FI102084B1 (fi) Menetelmä muokattujen nukleiinihappojen valmistamiseksi ja menetelmä niiden osoittamiseksi sekä reagenssipakkaus
DE3576568D1 (de) Verfahren zur erfassung des sauerstoffpartialdruckes.
DE60229785D1 (de) Rezeptoreinfang-assay
DE59910237D1 (de) Verfahren zur automatischen taktfreien Erkennung von Signal-Modulationsarten
DE59201030D1 (de) Verfahren zur ermittlung der grösse von parametern.
DE69918132D1 (de) Verfahren zur erkennung und messung von gespleisten nukleinsäuren
DE69626310D1 (de) Screening verfahren
DE69023710D1 (de) Verfahren zur bestimmung von enzymatischer wirksamkeit.
DE69719726D1 (de) Verfahren zur Detektion von Leukämie
IT1267410B1 (it) Procedimento per la determinazione di biomolecole mediante un sistema di amplificazione enzimatica.
DE3851170D1 (de) Verfahren zur Erkennung von Rauschen in Bildsignalen.
ATE74436T1 (de) Verfahren zur messung polarisierter fluoreszenzemission.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time